LONDON, Dec 30 (Reuters) - The Oxford University-AstraZeneca
COVID-19 vaccine approved by Britain on Wednesday provides a
path out of the pandemic by the spring, by which time millions
of vulnerable people will be protected, Health Secretary Matt
Hancock said.
He said the recommended 12-week gap between the first and
second doses of the Oxford-AstraZeneca shot was "very helpful"
because it enabled more people to be immunized with a first shot
that offered a high level of protection on its own.
(Reporting by Paul Sandle; editing by Guy Faulconbridge)
Astrazeneca (AZN)
